| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.09 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.086 | 0.09 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.051 | 0.09 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |